Hull man says having breast cancer makes him feel 'an imposter'
On his most recent visit to a hospital breast clinic, Neil Ferriby noticed the surprise of the female patients who filled the waiting room when he was called forward.It is moments like those that have contributed to the 42-year-old feeling "almost an imposter" since he was diagnosed with male breast cancer."The room was noisy and then, as soon as they said 'Neil', you could hear a pin drop. They were all staring at me," he said."I guess they don't expect men of my age to get breast cancer."The former RAF mechanical transport driver from east Hull has an elasticated support strapped around his chest, helping his recovery from surgery to remove 13 lymph nodes and three tumours.Warning: This story includes a post-surgery picture
Mr Ferriby said he had first noticed a lump and a burning sensation around his nipple in January, but dismissed them as harmless."In my head, it was kind of like, it's only females what get breast cancer, or males in their 60s plus," he said.Four weeks passed before his family and friends persuaded him to see his GP. He was referred to Castle Hill Hospital in East Yorkshire for a mammogram and ultrasound.In March, a biopsy found cancerous cells and, after surgery in April, he started chemotherapy this week.Mr Ferriby completed a tour of Iraq during his 12 years of RAF service and said the experience had helped him cope with the diagnosis."It's gone back to the military mindset that even if you're injured you still fight, and I'm here to fight, not to let cancer take me," he said.
The charity Breast Cancer Now said approximately 400 men were diagnosed with breast cancer each year in the UK, compared with about 55,000 women.Of those men, only about 100 are under 60.Katy Goford, the charity's clinical nurse specialist, said all men had breast tissue and should be as aware of changes as women."It's the same message we would put to women - that you need to be aware of what your chest looks and feels like normally," she said. "We'd encourage everybody to touch, to look and to check your chest and to report any changes that you see to your GP."The charity, which offers a helpline and a buddy service to match men with other male breast cancer patients, said being diagnosed with breast cancer could be "very isolating" for men.
'Guinea pig'
Mr Ferriby said he had become aware of how unusual his case was when the number of people coming into his appointments increased from a doctor and a nurse to "coachloads" of people.But, keen to raise awareness of how breast cancer presents in men, he said he was happy staff and students were able to learn from him."I don't mind being a guinea pig for the NHS," he said. Mr Ferriby said he had found his local breast cancer support charity supportive, despite having reservations initially. He said: "It's called HER Breast Friends, so I emailed 'Do you actually deal with males?'"But the email I got back was so lovely, they said 'Yes, and come to our pamper day'."
According to the NHS website, breast cancer symptoms can include:a lump, or swelling in your breast, chest or armpita change in the skin of your breast, such as dimpling or rednessa change in size or shape of one or both breastsnipple discharge (if you are not pregnant or breastfeeding), which may have blood in ita change in the shape or look of your nipple, such as it turning inwards or a rash on itpain in your breast or armpit which does not go away
'Don't leave it four weeks'
Mr Ferriby said, after completing his chemotherapy, he would need radiotherapy and would take the drug Tamoxifen for 10 years.He is raising funds for the charity Macmillan, whose nurses are helping him through his cancer journey.Mr Ferriby said he wanted to make men more aware they could contract breast cancer."Everything that you see - posters, TV adverts - it's mainly all being geared towards women," he said. "If there's any men out there, especially my age or younger, and they find something in the chest wall that doesn't feel right, maybe don't leave it four weeks to go to the GP like I did."If you have been affected by the issues raised in this article, you can visit the BBC Action Line for information and supportListen to highlights from Hull and East Yorkshire on BBC Sounds, watch the latest episode of Look North or tell us about a story you think we should be covering here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
32 minutes ago
- Telegraph
NHS patients to receive drug that destroys cancer from inside
A so-called 'Trojan Horse' drug that destroys blood cancer from within is set to be rolled out to thousands of NHS patients. The health service will be the first in the world to make the drug available to patients with multiple myeloma – an incurable cancer of the bone marrow. The drug, called belantamab mafadotin, was developed in the UK and has been dubbed a 'Trojan Horse' therapy because it tricks cancer cells into absorbing it before killing them from within. While the cancer is incurable, treatment is designed to extend people's lives by as much as possible while minimising the impact of side effects and on quality of life. In trials, cancer progression was delayed by three years on average in those taking the drug, which was three times longer than the most common treatment. Around 1,500 patients a year in England will benefit after the treatment was approved by the National Institute for Health and Care Excellence on Thursday. The drug will be offered to patients whose cancer has progressed or not responded to the first choice of treatment using another drug, lenalidomide. Patients who are prescribed the drug will receive it via an infusion once every three weeks in combination with two other cancer treatments.
The Guardian
an hour ago
- The Guardian
Blood cancer patients in England first in world to be offered ‘Trojan horse' drug
Thousands of patients in England with blood cancer will become the first in the world to be offered a pioneering 'Trojan horse' drug that sneaks inside cancer cells and wipes them out. In guidance published on Friday, the National Institute for Health and Care Excellence (Nice) gave the green light to belantamab mafodotin, which can halt the advance of multiple myeloma for three times as long as standard treatments. The targeted therapy, which is given as an infusion every three weeks with other cancer drugs, is a special type of antibody drug that targets and attaches to cancer cells. It has been described as a Trojan horse treatment because it works by being taken into a cancer cell and unleashing a high concentration of a lethal molecule to destroy the cell from inside. Prof Peter Johnson, NHS England's national clinical director for cancer, said the drug would be life-changing for patients and their families. 'Myeloma is an aggressive type of blood cancer, but we have seen a steady improvement in the outlook for patients over recent years as we have introduced new targeted therapies,' he said. 'I am delighted that patients in England will be the first to benefit from this new treatment, which has the potential to keep cancer at bay for years longer, giving people the chance of more precious time with friends and family.' About 1,500 patients a year in England with multiple myeloma, an incurable cancer of the bone marrow, will benefit from the treatment, also known as Blenrep and made by GlaxoSmithKline. Health officials said the drug would be offered to patients whose cancer had progressed or failed to respond to another first-line treatment. Shelagh McKinlay, the director of research and advocacy at the blood cancer charity Myeloma UK, said it was fantastic to see the NHS become the first healthcare system in the world to roll out the drug. 'We have been working very hard for the last year to get this treatment approved and we know it will transform the lives of thousands of people with myeloma,' she said. Paul Silvester, 60, from Sheffield, described the impact of the drug as amazing after he was diagnosed with myeloma in 2023. After the first treatment he received failed to stop his cancer progressing, he was given belantamab mafodotin through an early access programme at the Royal Hallamshire hospital. 'I feel like this treatment has brought the party balloons back in the house. It has been amazing – within the first two or three weeks, after the first dose, I was in remission,' he said. Trials suggest the treatment, in combination with bortezomib and dexamethasone, delays progression of the disease by an average of three years, compared with one year for patients taking the commonly used drug daratumumab along with the other treatments. Helen Knight, the director of medicines evaluation at Nice, said: 'This recommendation demonstrates our commitment to getting the best care to patients fast, while ensuring value for the taxpayer.' The health minister Karin Smyth said: 'This groundbreaking therapy puts the NHS at the forefront of cancer innovation. By harnessing cutting-edge 'Trojan horse' technology, we're offering new hope to blood cancer patients across the country.'
BBC News
an hour ago
- BBC News
Kidney Research UK boss appointed OBE at special ceremony
A charity chief executive who has overseen more than £71m being ploughed into research for kidney disease has become an OBE at a special Currie, from Northampton, has been at Peterborough-based Kidney Research UK for more than 12 Wednesday she visited Windsor Castle to be appointed an Officer of the Order of the British Empire (OBE) by the Prince of Wales, which she called a "very special moment".She was recognised in the King's New Year Honours list earlier this year for her services to people affected by the disease. "To represent the kidney community in such a setting was incredibly humbling," she explained. "This honour helps raise the profile of a disease that affects one-in-ten people in the UK, can have devastating consequences for those who reach kidney failure, but is still overlooked. "I'm grateful for the recognition, and more determined than ever to keep pushing for change."There are more than 7.2m people living in the UK with kidney disease, including more than 80,000 in Northamptonshire, the charity Currie has worked to invest millions into research, as well as improve awareness of the disease. Follow Northamptonshire news on BBC Sounds, Facebook, Instagram and X.
